Username:

Password:
 
ABOUT HIV PREVENTION TREATMENT NEWS COMMUNITY ABOUT US EN ESPAÑOL POZ MAGAZINE

Back to home » News & Views » Treatment News

 
September 28, 2007
Past Lexiva Treatment May Reduce Benefit From Prezista
September 27, 2007
Ban on European Viracept Sales Lifted
KP-1461: A New Approach to HIV Treatment Now in Studies
September 26, 2007
Genetic Tests Could Help Reduce Sustiva Side Effects
September 25, 2007
High Rate of Kidney Problems in HIV
Dry Skin More Common in Positive People
September 24, 2007
Etravirine for NNRTI-Resistant HIV: Pooled DUET Study Results
Activist Seek Fair Price for Isentress
Maraviroc Gets EU Approval
September 21, 2007
Single-Dose PRO 140 Has Lasting Effects
48-Week Selzentry Data Show Promise for Drug-Resistant HIV
September 20, 2007
Wisdom for Women: An Expert's Take on HIV and Gender Differences
Selzentry Treatment Failure: The Impact of Tropism Changes
Two-Year Vicriviroc Benefit in Treatment-Experienced Patients
FDA Grants Priority Review for New NNRTI, Etravirine
HIV Prevalence Declines in Pregnant Women in Zimbabwe
September 19, 2007
Coming Down the Pike: Expanding HIV Treatment Options
IL-2 May Delay Need for Antiretroviral Treatment
Elvitegravir Study Highlights Value of Strong Background Regimen
New Data Explores Current Treatment Options
September 18, 2007
Interview with a Hep C Activist & Survivor
Heart Disease Risk Remains in Absence of HIV Treatment
Prezista Shows Well in Patients New to Treatment
Isentress Offers Long-Term Benefits for Drug-Resistant Patients
Secrets of a Long-Term Survivor
September 17, 2007
High Risk of Peripheral Artery Disease in HIV
Lexiva and Kaletra Comparable in Long-Term Study
September 14, 2007
Pregnancy Protective Against HIV Disease Progression
Skin Test Predicts Control of HPV
September 13, 2007
More Reports on Kidney Stones With Reyataz
September 12, 2007
Lasting CD4 Increases With IL-2
September 11, 2007
Pfizer Warns of Cancerous Impurity in Viracept
HIV Damages Brain Despite Treatment
September 10, 2007
High-Fat Diets Affect Disease Progression
September 07, 2007
Study Suggests Treating Hep C Before HIV
September 06, 2007
Isentress Recommended for FDA Approval
September 05, 2007
Promising New Nuke, Apricitabine
September 04, 2007
Needle-Free Device Improves Life for Fuzeon Users
Metformin Shows Little Lipodystrophy Benefit in Small Study

 

May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
 






Michelle



Glenn



Hilary
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertise/contact us | site map]
© 2008 Smart + Strong. All Rights Reserved. terms of use and your privacy